サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565079

オルガン・オン・チップスの世界市場

Organs-on-Chips

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
オルガン・オン・チップスの世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

オルガン・オン・チップスの世界市場は2030年までに5,585億米ドルに到達

2023年に672億米ドルと推定されたオルガン・オン・チップスの世界市場は、分析期間2023-2030年にCAGR 35.3%で成長し、2030年には5,585億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるLiver-on-Chipは、CAGR 36.6%を記録し、分析期間終了時には2,060億米ドルに達すると予測されます。腎臓オンチップ分野の成長率は、分析期間中CAGR37.4%と推定されます。

米国市場は188億米ドルと推定、中国はCAGR33.4％で成長すると予測

米国のオルガン・オン・チップス市場は、2023年に188億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに799億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは33.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ31.8%と29.9%と予測されています。欧州では、ドイツがCAGR約24.3%で成長すると予測されています。

世界のオルガン・オン・チップス市場- 主要動向と促進要因まとめ

オルガン・オン・チップスとは何か、なぜ生物医学調査に革命をもたらすのか？

オルガン・オン・チップスは、生きた細胞と高度なマイクロ流体システムを組み合わせることにより、人間の臓器の機能や構造を模倣したマイクロ工学デバイスです。これらのデバイスは通常、柔軟で半透明の材料で作られており、細胞の挙動をリアルタイムでモニタリング・分析できるため、研究者は高度に制御された環境で臓器の機能や病気のプロセスを調査することができます。オルガン・オン・チップスは、肺、肝臓、腎臓、心臓など特定の臓器の生理的状態をシミュレートすることで、従来の動物実験や細胞培養に代わる強力な選択肢を提供します。オルガン・オン・チップスの潜在的な応用範囲は、創薬、疾患モデリング、個別化医療に及びます。製薬会社や研究機関は、これらのデバイスを使用して、より正確に薬効や毒性をテストし、動物モデルへの依存を減らし、ヒトベースの研究の精度を高めています。個別化医療が注目される中、個々の患者の反応をモデル化するオルガン・オン・チップスの能力は、生物医学研究分野を変革する可能性をさらに浮き彫りにしています。

技術革新はオルガン・オン・チップス業界をどのように前進させていますか？

オルガン・オン・チップス市場は、材料科学、マイクロ流体工学、組織工学の革新により急速な成長を遂げています。3Dバイオプリンティングとマイクロファブリケーション技術の進歩により、オルガン・オン・チップスのデザインと機能性が大幅に向上し、個々の臓器の機能だけでなく、異なる臓器間の相互作用も再現できる、より複雑な多組織モデルの作成が可能になりました。このような技術の進歩により、「ボディーオンチップ」モデルとしても知られる、相互接続された臓器システムの作成が可能になり、人体における薬物や疾患の全身的な影響をよりよくシミュレートできるようになりました。さらに、センサー技術やイメージング技術の発展により、細胞反応をリアルタイムでモニターする能力が向上し、薬物や病気のプロセスが細胞レベルで人体組織にどのような影響を与えるかについての詳細な洞察が得られるようになっています。研究者はまた、人工知能（AI）や機械学習アルゴリズムを統合してオルガン・オン・チップスから生成されるデータを分析し、薬物毒性や治療成績の予測モデルを強化することを模索しています。このような進歩により、オルガン・オン・チップスの学術研究および産業環境への導入が加速しています。

オルガン・オン・チップスはどこで最も使われていますか？

オルガン・オン・チップスは、製薬業界、学術研究、個別化医療で幅広く使用されています。製薬会社は、医薬品の安全性と有効性を評価するための従来の方法よりも信頼性が高く、コスト効率の高い方法を提供するため、創薬や前臨床試験でこれらの機器への依存度を高めています。 オルガン・オン・チップスは人間の臓器反応を忠実に再現できるため、潜在的な薬剤候補のスクリーニングや、開発プロセスの初期段階での毒性作用の特定に理想的です。学術研究および生物医学研究において、オルガン・オン・チップスはがん、心血管系疾患、神経疾患などの幅広い疾患のモデルとして採用されています。これらのモデルにより、研究者は病気のメカニズムを調査し、ヒトに関連した状況で新しい治療法をテストすることができます。個別化医療では、オルガン・オン・チップスは患者特異的治療法を開発するためのツールとして研究されており、個々の患者の細胞を用いて、治療に対する反応を予測するカスタム臓器モデルを作成することができます。これは、治療効果が患者によって大きく異なる可能性のあるがんのような疾患において、特に有益です。

オルガン・オン・チップス市場の成長の促進要因は？

オルガン・オン・チップス市場の成長は、動物実験に代わるものへの需要の高まり、個別化医療の台頭、マイクロ流体工学や組織工学の技術進歩など、いくつかの要因によってもたらされます。主要な促進要因のひとつは、従来の動物モデルでは薬物や疾患に対するヒトの反応を正確に予測できないことが多いという認識が広まり、より信頼性の高いヒトベースの試験プラットフォームに対する需要が生まれていることです。倫理的な懸念とともに、動物実験を減らすという規制上の圧力が、より人道的で科学的に確実な代替手段としてのオルガン・オン・チップスへの関心をさらに高めています。さらに、個々の患者に合わせた治療を行う個別化医療の台頭により、患者固有の薬物反応を予測できるカスタマイズされた臓器モデルの需要が高まっています。マイクロファブリケーションと組織工学の進歩もまた、オルガン・オン・チップスの能力を拡大し、より汎用性が高く、幅広い用途に利用できるようになっています。最後に、生物医学研究への投資の増加と学術機関、製薬会社、政府機関の協力により、世界中でオルガン・オン・チップスの採用と商業化が加速しています。

調査対象企業の例（全12件）

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13775

Global Organs-on-Chips Market to Reach US$558.5 Billion by 2030

The global market for Organs-on-Chips estimated at US$67.2 Billion in the year 2023, is expected to reach US$558.5 Billion by 2030, growing at a CAGR of 35.3% over the analysis period 2023-2030. Liver-on-Chip, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth in the Kidney-on-Chip segment is estimated at 37.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$18.8 Billion While China is Forecast to Grow at 33.4% CAGR

The Organs-on-Chips market in the U.S. is estimated at US$18.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$79.9 Billion by the year 2030 trailing a CAGR of 33.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 31.8% and 29.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 24.3% CAGR.

Global Organs-on-Chips Market – Key Trends & Drivers Summarized

What Are Organs-on-Chips, and Why Are They Revolutionizing Biomedical Research?

Organs-on-chips are micro-engineered devices that mimic the functions and structures of human organs by combining living cells with advanced microfluidic systems. These devices are typically made from flexible, translucent materials that allow for real-time monitoring and analysis of cellular behavior, enabling researchers to study organ function and disease processes in a highly controlled environment. By simulating the physiological conditions of specific organs—such as the lung, liver, kidney, or heart—organs-on-chips offer a powerful alternative to traditional animal testing and cell cultures. The potential applications for organs-on-chips extend across drug discovery, disease modeling, and personalized medicine. Pharmaceutical companies and research institutions are using these devices to test drug efficacy and toxicity more accurately, reducing the reliance on animal models and increasing the precision of human-based studies. As personalized medicine gains prominence, the ability of organs-on-chips to model individual patient responses further highlights their potential to transform the field of biomedical research.

How Are Technological Innovations Advancing the Organs-on-Chips Industry?

The organs-on-chips market is experiencing rapid growth due to innovations in materials science, microfluidics, and tissue engineering. Advances in 3D bioprinting and microfabrication technologies have significantly enhanced the design and functionality of organs-on-chips, enabling the creation of more complex, multi-tissue models that can replicate not just individual organ functions, but also the interactions between different organs. These technological strides allow for the creation of interconnected organ systems, also known as "body-on-a-chip" models, which better simulate the systemic effects of drugs and diseases in the human body. Further, developments in sensor technologies and imaging techniques are improving the ability to monitor cellular responses in real time, providing detailed insights into how drugs or disease processes affect human tissue at the cellular level. Researchers are also exploring the integration of artificial intelligence (AI) and machine learning algorithms to analyze data generated from organs-on-chips, enhancing predictive models for drug toxicity and therapeutic outcomes. These advances are accelerating the adoption of organs-on-chips in both academic research and industrial settings.

Where Are Organs-on-Chips Being Used Most Prominently?

Organs-on-chips are being used extensively in the pharmaceutical industry, academic research, and personalized medicine. Pharmaceutical companies are increasingly relying on these devices for drug discovery and preclinical testing, as they offer a more reliable and cost-effective way to evaluate drug safety and efficacy than traditional methods. The ability of organs-on-chips to replicate human organ responses with high fidelity makes them ideal for screening potential drug candidates and identifying toxic effects early in the development process. In academic and biomedical research, organs-on-chips are being employed to model a wide range of diseases, including cancer, cardiovascular conditions, and neurological disorders. These models allow researchers to investigate disease mechanisms and test new treatments in a human-relevant context. In personalized medicine, organs-on-chips are being explored as a tool for developing patient-specific therapies, where cells from individual patients can be used to create custom organ models that predict how they will respond to treatments. This is especially valuable for conditions such as cancer, where treatment responses can vary significantly between patients.

What Is Driving the Growth of the Organs-on-Chips Market?

The growth in the organs-on-chips market is driven by several factors, including the increasing demand for alternatives to animal testing, the rise of personalized medicine, and technological advancements in microfluidics and tissue engineering. One of the key drivers is the growing recognition that traditional animal models often fail to accurately predict human responses to drugs and diseases, creating a demand for more reliable, human-based testing platforms. Regulatory pressure to reduce animal testing, along with ethical concerns, has further fueled interest in organs-on-chips as a more humane and scientifically robust alternative. Additionally, the rise of personalized medicine, where treatments are tailored to individual patients, is driving demand for customized organ models that can predict patient-specific drug responses. Advances in microfabrication and tissue engineering are also expanding the capabilities of organs-on-chips, making them more versatile and accessible for a broader range of applications. Finally, increasing investment in biomedical research, coupled with collaborations between academic institutions, pharmaceutical companies, and government agencies, is accelerating the adoption and commercialization of organs-on-chips across the globe.

Select Competitors (Total 12 Featured) -

  • Ascendance Biotechnology, Inc.
  • AxoSim, Inc.
  • CN Bio Innovations Ltd.
  • Emulate, Inc.
  • Hurel Corporation
  • InSphero AG
  • Kirkstall Ltd.
  • Mimetas
  • Nortis, Inc.
  • SynVivo
  • TissUse GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Organs-on-Chips - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Personalized Medicine and Drug Testing Spurs Growth in the Organs-on-Chips Market
    • Increasing R&D Investments in Biotechnology Strengthens Business Case for Organs-on-Chips in Drug Development
    • Advancements in Microfluidics and Tissue Engineering Propel Innovation in Organs-on-Chips Technology
    • Surge in Demand for Alternative Testing Methods Expands Market for Organs-on-Chips in Toxicity Testing
    • Rising Ethical Concerns Over Animal Testing Accelerates Adoption of Organs-on-Chips in Biomedical Research
    • Growing Application of Organs-on-Chips in Precision Medicine Expands Addressable Market for Personalized Drug Screening
    • Increasing Use of Organs-on-Chips in Disease Modeling Drives Growth in Research and Development
    • Advancements in 3D Bioprinting Technology Propel Innovation in Customizable Organs-on-Chips Platforms
    • Rising Demand for Predictive and High-Throughput Screening in Drug Discovery Fuels Adoption of Organs-on-Chips
    • Increasing Focus on Human Physiology Replication Strengthens Business Case for Organs-on-Chips in Preclinical Studies
    • Rising Use of Organs-on-Chips in Cardiovascular and Neurological Disease Studies Fuels Market Expansion
    • Increasing Application of Organs-on-Chips in Oncology and Cancer Research Propels Market Growth
    • Advancements in Integration of Sensors and Real-Time Data Analysis in Organs-on-Chips Drive Market Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Organs-on-Chips Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Kidney by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Kidney by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Lung by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Lung by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Heart by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Heart by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cosmetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Cosmetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: USA 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Canada 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • JAPAN
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • CHINA
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 34: China Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 36: China Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 37: China 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • EUROPE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Organs-on-Chips by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • FRANCE
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 44: France Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 46: France Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: France 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • GERMANY
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Germany 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • ITALY
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: Italy 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • UNITED KINGDOM
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 56: UK Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 58: UK Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: UK 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Organs-on-Chips Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by Type - Liver, Kidney, Lung, Heart and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Organs-on-Chips by Type - Percentage Breakdown of Value Sales for Liver, Kidney, Lung, Heart and Other Types for the Years 2024 & 2030
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Organs-on-Chips by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 71: Rest of World 7-Year Perspective for Organs-on-Chips by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Cosmetics and Other End-Uses for the Years 2024 & 2030

IV. COMPETITION